Variant report
Variant | rs1547628 |
---|---|
Chromosome Location | chr9:85882803-85882804 |
allele | A/C |
Outlinks | Ensembl   UCSC |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:85854800-85890400 | Weak transcription | Primary neutrophils fromperipheralblood | blood |
2 | chr9:85856200-85910600 | Weak transcription | Monocytes-CD14+_RO01746 | blood |
3 | chr9:85866200-85913000 | Weak transcription | Aorta | Aorta |
4 | chr9:85880600-85883200 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
5 | chr9:85881200-85883000 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
6 | chr9:85881400-85883000 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
7 | chr9:85881400-85883000 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
8 | chr9:85881400-85883800 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
9 | chr9:85881600-85883000 | Enhancers | HUES6 Cell Line | embryonic stem cell |
10 | chr9:85881600-85883200 | Enhancers | HUES64 Cell Line | embryonic stem cell |
11 | chr9:85881600-85889000 | Weak transcription | Duodenum Smooth Muscle | Duodenum |
12 | chr9:85881800-85883000 | Enhancers | H1 Cell Line | embryonic stem cell |
13 | chr9:85882000-85885000 | Weak transcription | Spleen | Spleen |
14 | chr9:85882000-85886600 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
15 | chr9:85882000-85895800 | Weak transcription | Fetal Kidney | kidney |
16 | chr9:85882000-85895800 | Weak transcription | Rectal Mucosa Donor 31 | rectum |
17 | chr9:85882200-85883000 | Enhancers | Skeletal Muscle Male | skeletal muscle |
18 | chr9:85882200-85883200 | Enhancers | Skeletal Muscle Female | skeletal muscle |
19 | chr9:85882200-85883600 | Weak transcription | Fetal Muscle Trunk | muscle |
20 | chr9:85882200-85884800 | Weak transcription | Left Ventricle | heart |
21 | chr9:85882200-85884800 | Weak transcription | Psoas Muscle | Psoas |
22 | chr9:85882200-85884800 | Weak transcription | Right Atrium | heart |
23 | chr9:85882200-85884800 | Weak transcription | Right Ventricle | heart |
24 | chr9:85882200-85885000 | Weak transcription | Fetal Muscle Leg | muscle |
25 | chr9:85882200-85886600 | Weak transcription | Adipose Nuclei | Adipose |
26 | chr9:85882200-85886600 | Enhancers | Fetal Heart | heart |
27 | chr9:85882200-85887200 | Enhancers | HUVEC | blood vessel |
28 | chr9:85882200-85889400 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
29 | chr9:85882200-85889400 | Weak transcription | Fetal Stomach | stomach |
30 | chr9:85882200-85889800 | Weak transcription | Pancreas | Pancrea |
31 | chr9:85882200-85895800 | Weak transcription | Gastric | stomach |
32 | chr9:85882200-85895800 | Weak transcription | Ovary | ovary |
33 | chr9:85882200-85896000 | Weak transcription | Foreskin Fibroblast Primary Cells skin02 | Skin |
34 | chr9:85882400-85886400 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
35 | chr9:85882600-85883000 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
36 | chr9:85882600-85883200 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
37 | chr9:85882600-85883600 | Weak transcription | HepG2 | liver |
38 | chr9:85882800-85883000 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |